Can weight-loss drugs like Mounjaro reverse liver fibrosis?

Yes, studies and patient experiences suggest that GLP-1 weight-loss drugs, such as Mounjaro, can help reverse liver fibrosis and resolve fatty liver disease.

What is fatty liver disease and its link to obesity?

Fatty liver disease is a condition characterized by excess fat in the liver, often triggered by long-term inflammation linked to obesity and sedentary lifestyles.

Are GLP-1 drugs approved on the NHS for liver disease?

Currently, GLP-1 drugs are not approved on the NHS for treating liver disease, though a decision is expected this summer.

Home / Health / Liver Fibrosis Reversal Achieved with Weight-Loss Drugs

Liver Fibrosis Reversal Achieved with Weight-Loss Drugs

8 Feb

•

Summary

Weight-loss drugs show promise in reversing liver fibrosis.
GLP-1 drugs like Mounjaro aid in liver health recovery.
Studies indicate significant fatty liver disease resolution with these medications.

Liver Fibrosis Reversal Achieved with Weight-Loss Drugs

Belinda Whitlock's journey from debilitating fatigue to overcoming advanced liver fibrosis highlights the transformative potential of GLP-1 weight-loss drugs. Initially dismissed as menopause symptoms, her condition was revealed by an ultrasound, leading to a diagnosis of liver fibrosis due to fatty liver disease.

After lifestyle changes yielded limited results, Whitlock sought private prescriptions for GLP-1 drugs, including Mounjaro. This decision led to substantial weight loss and, remarkably, the reversal of her liver fibrosis, a condition previously considered irreversible.

Experts like Professor Philip Newsome from King's College London are optimistic about these drugs. Compelling research indicates they can reverse liver damage, a feat once thought impossible. The surge in liver disease cases, linked to poor diet and sedentary lifestyles, makes these findings particularly significant.